跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Levecortix-250
Approved
STANDARD
Levecortix-250
Umedica Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9fed4b733b58f22d
Company
Umedica Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
9fed4b733b58f22d
Drug Approval Philippines Name
Levecortix-250
Product Name
Levecortix-250
Registration Number
DRP-5968-07
Brand Name
Levecortix-250
Generic Name
Hydrocortisone (as sodium succinate)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
250 mg
Manufacturer
Umedica Laboratories Pvt. Ltd.
Importer
Suhitas Pharmaceuticals, Inc.
Distributor
HLM Leverage Pharmaceutical Co.
Company Detail Path
/organization/umedica-laboratories-pvt-ltda
Issuance Date
23 December 2024
Expiry Date
29 January 2030
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9fed4b733b58f22d
Type
Standard
Back to Philippines FDA Approvals
Levecortix-250 - Philippines FDA Drug Approval Details